Presentations Precision Medicine – A Pathologist’s Perspective (Matthew Burtelow, MD, PhD) Update from the ISCO Board Retreat (Dan Zuckerman, MD) Insights Into Precision Medicine from an Informatics Perspective (Ryan Abo, PhD) Understanding the Role of the Human G-I Microbiome in … Continued
FDA modified the dosage regimen for nivolumab (Opdivo, Bristol-Myers Squibb Co.) for the currently approved indications for renal cell carcinoma, metastatic melanoma, and non-small cell lung cancer. The currently approved recommended dosage regimens were modified to 240 mg intravenously (IV) … Continued
Please head over to http://www.ccaidaho.org/resources to check out the newly updated breast, cervical and colorectal cancer factsheets! These factsheets are geared towards healthcare professionals and are best viewed electronically or printed on legal sized paper.